A five-year observational prospective mono centre study of efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis

被引：0

作者：

Sandgren, Sofia ^{[1
]}

Novakova, Lenka ^{[1
]}

Nordin, Anna ^{[1
]}

Axelsson, Markus ^{[1
]}

Malmestrom, Clas ^{[1
,2
]}

Zetterberg, Henrik ^{[3
,4
,5
,6
]}

Lycke, Jan ^{[1
]}

机构：

[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden

[2] Univ Gothenburg, Sahlgrenska Acad, Lab Clin Immunol, Gothenburg, Sweden

[3] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden

[4] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England

[5] UCL, UK Dementia Res Inst, London, England

[6] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P733/775

引用

页码：632 / 633

页数：2